<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="id29dd29b7-3271-11e3-81c9-db9a7820b8d4" identifier="/us/usc/t21/s813"><num value="813">§ 813.</num><heading> Treatment of controlled substance analogues</heading><content>
<p style="-uslm-lc:I11" class="indent0">A controlled substance analogue shall, to the extent intended for human consumption, be treated, for the purposes of any Federal law as a controlled substance in schedule I.</p>
</content><sourceCredit id="id29dd29b8-3271-11e3-81c9-db9a7820b8d4">(<ref href="/us/pl/91/513/s203">Pub. L. 91–513, title II, § 203</ref>, as added <ref href="/us/pl/99/570/s1202">Pub. L. 99–570, title I, § 1202</ref>, <date date="1986-10-27">Oct. 27, 1986</date>, <ref href="/us/stat/100/3207-13">100 Stat. 3207–13</ref>; amended <ref href="/us/pl/100/690/s6470/c">Pub. L. 100–690, title VI, § 6470(c)</ref>, <date date="1988-11-18">Nov. 18, 1988</date>, <ref href="/us/stat/102/4378">102 Stat. 4378</ref>.)</sourceCredit>
<notes type="uscNote" id="id29dd29b9-3271-11e3-81c9-db9a7820b8d4">
<note style="-uslm-lc:I75" topic="referencesInText" id="id29dd29ba-3271-11e3-81c9-db9a7820b8d4">
<heading class="centered smallCaps">References in Text</heading><p style="-uslm-lc:I21" class="indent0">Schedule I, referred to in text, is set out in <ref href="/us/usc/t21/s812/c">section 812(c) of this title</ref>.</p>
</note>
<note style="-uslm-lc:I74" topic="amendments" id="id29dd29bb-3271-11e3-81c9-db9a7820b8d4"><heading class="centered smallCaps">Amendments</heading><p style="-uslm-lc:I21" class="indent0">1988—<ref href="/us/pl/100/690">Pub. L. 100–690</ref> substituted “any Federal law” for “this subchapter and subchapter II of this chapter”.</p>
</note>
</notes>
</section>